{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:12:11Z","timestamp":1784164331588,"version":"3.55.0"},"reference-count":18,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Pulmonology"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Increasing evidence has demonstrated the effectiveness and safety of corticosteroids in community\u2010acquired pneumonia in children. More economic evaluations incorporating the new evidence and in the pediatric population are needed to know the efficiency of this treatment. This study aimed to evaluate the cost utility of the use of corticosteroids as adjuvant treatment for children with Mycoplasma pneumonia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A decision tree model was used to estimate the cost and quality adjusted life years\u00a0(QALY) associated with cost\u2010effectiveness as an adjunct treatment for children with Mycoplasma pneumonia with persistent signs after standard treatment with macrolide drugs for \u22651 week. Multiple sensitivity analyses were conducted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The QALYs per person estimated in the model for those treatments were 0.92 with corticosteroids plus antibiotics and 0.91 with antibiotics. The total costs per person were US$965 for corticosteroids plus antibiotics and US$1271 for antibiotics. This position of absolute dominance of corticosteroids plus antibiotics over antibiotics makes it unnecessary to estimate the incremental cost\u2010effectiveness ratio.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Corticosteroids are cost\u2010effective as an adjunct treatment for children with <jats:italic>Mycoplasma pneumoniae<\/jats:italic> pneumonia with persistent signs after standard treatment with macrolide drugs for \u22651 week. Our evidence should motivate the evaluation of this treatment in other countries.<\/jats:p><\/jats:sec>","DOI":"10.1002\/ppul.26592","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T12:27:50Z","timestamp":1689078470000},"page":"2809-2814","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Corticosteroids for the treatment of respiratory infection by <i>Mycoplasma pneumoniae<\/i> in children: A cost\u2010utility analysis"],"prefix":"10.1002","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2404-6612","authenticated-orcid":false,"given":"Jefferson A.","family":"Buend\u00eda","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, Research Group in Pharmacology and Toxicology \u201cINFARTO\u201d University of Antioquia Medellin Colombia"},{"name":"Health Economics Research Centre, Nuffield Department of Population Health University of Oxford  Oxford United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7731-4460","authenticated-orcid":false,"given":"Diana Guerrero","family":"Pati\u00f1o","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Research Group in Pharmacology and Toxicology \u201cINFARTO\u201d University of Antioquia Medellin Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,7,11]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30408-X"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-204247"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/8755122521995587"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050541"},{"key":"e_1_2_11_6_1","article-title":"Corticosteroids for pneumonia","volume":"12","author":"Stern A","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014636"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2395-8"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002529"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020121"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.11.001"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czab146"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.12804\/revistas.urosario.edu.co\/revsalud\/a.6115"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.01.040"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.02.010"},{"key":"e_1_2_11_16_1","unstructured":"Moyano ArizaL.Estimaci\u00f3n de costo\u2010enfermedad por neumon\u00eda y bronquiolitis en ni\u00f1os menores de 5 a\u00f1os en Colombia. 2019."},{"key":"e_1_2_11_17_1","unstructured":"Ministerio de saludC. Sistema de Informacion de Precios de Medicamentos (SISMED). 2021. Accessed July 3 2021.\u00a0www.sispro.gov.co\/central-prestadores-de-servicios\/Pages\/SISMED-Sistema-de-Informacion-de-Precios-de-Medicamentos.aspx"},{"key":"e_1_2_11_18_1","unstructured":"(DANE) DNdE. Archivo nacional de datos.\u00a02019.\u00a0https:\/\/sitios.dane.gov.co\/anda-index\/"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1050(199906)8:4<323::AID-HEC431>3.0.CO;2-0"}],"container-title":["Pediatric Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ppul.26592","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T14:43:42Z","timestamp":1703774622000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ppul.26592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,11]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1002\/ppul.26592"],"URL":"https:\/\/doi.org\/10.1002\/ppul.26592","archive":["Portico"],"relation":{},"ISSN":["8755-6863","1099-0496"],"issn-type":[{"value":"8755-6863","type":"print"},{"value":"1099-0496","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,11]]},"assertion":[{"value":"2022-12-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}